Literature DB >> 26255084

Correlation between delay in initiating clozapine and symptomatic improvement.

Yuji Yada1, Bunta Yoshimura2, Yoshiki Kishi1.   

Abstract

Entities:  

Keywords:  Clozapine; Delay; Schizophrenia; Treatment-resistant

Mesh：

Substances：

Year:  2015        PMID： 26255084     DOI： 10.1016/j.schres.2015.07.045

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors:  Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-19       Impact factor: 5.270

Review 2.  Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.

Authors:  Masataka Wada; Yoshihiro Noda; Yusuke Iwata; Sakiko Tsugawa; Kazunari Yoshida; Hideaki Tani; Yoji Hirano; Shinsuke Koike; Daiki Sasabayashi; Haruyuki Katayama; Eric Plitman; Kazutaka Ohi; Fumihiko Ueno; Fernando Caravaggio; Teruki Koizumi; Philip Gerretsen; Takefumi Suzuki; Hiroyuki Uchida; Daniel J Müller; Masaru Mimura; Gary Remington; Anthony A Grace; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2022-04-20       Impact factor: 15.992

3.  A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia.

Authors:  C U Correll; Ofer Agid; Benedicto Crespo-Facorro; Andrea de Bartolomeis; Andrea Fagiolini; Niko Seppälä; Oliver D Howes
Journal:  CNS Drugs       Date:  2022-06-27       Impact factor: 6.497

4.  Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie : revue systématique des études longitudinales en neuroimagerie.

Authors:  Anaïs Vandevelde; Lucie Métivier; Sonia Dollfus
Journal:  Can J Psychiatry       Date:  2020-11-02       Impact factor: 4.356

5.  Deficits in attentional modulation of auditory N100 in first-episode schizophrenia.

Authors:  Xi Ren; Sarah N Fribance; Brian A Coffman; Dean F Salisbury
Journal:  Eur J Neurosci       Date:  2021-02-12       Impact factor: 3.698

6.  Delaying clozapine: how long is too long?

Authors:  Tom Varghese M; K S Jyothi; K S Shaji; Lekshmi Rita Venugopal
Journal:  Gen Psychiatr       Date:  2020-04-28

Review 7.  The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.

Authors:  Steven G Potkin; John M Kane; Christoph U Correll; Jean-Pierre Lindenmayer; Ofer Agid; Stephen R Marder; Mark Olfson; Oliver D Howes
Journal:  NPJ Schizophr       Date:  2020-01-07

8.  Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.

Authors:  Norio Yasui-Furukori; Hiroyuki Muraoka; Naomi Hasegawa; Shinichiro Ochi; Shusuke Numata; Hikaru Hori; Akitoyo Hishimoto; Toshiaki Onitsuka; Kazutaka Ohi; Naoki Hashimoto; Tatsuya Nagasawa; Yoshikazu Takaesu; Takahiko Inagaki; Hiromi Tagata; Takashi Tsuboi; Chika Kubota; Ryuji Furihata; Jun-Ichi Iga; Hitoshi Iida; Kenichiro Miura; Junya Matsumoto; Hisashi Yamada; Koichiro Watanabe; Ken Inada; Kazutaka Shimoda; Ryota Hashimoto
Journal:  Neuropsychopharmacol Rep       Date:  2021-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.